{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:18:14Z","timestamp":1787764694488,"version":"build-2784847793"},"reference-count":111,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dentistry Journal"],"abstract":"<jats:p>This narrative review addresses the role of a dentist in the management of oncology patients, highlighting the oral complications that arise in head and neck radiation oncology patients and medical oncology patients. The prevention and management of these complications are discussed.<\/jats:p>","DOI":"10.3390\/dj11050136","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T06:00:29Z","timestamp":1684389629000},"page":"136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Role of Dental Practitioners in the Management of Oncology Patients: The Head and Neck Radiation Oncology Patient and the Medical Oncology Patient"],"prefix":"10.3390","volume":"11","author":[{"given":"Adepitan A.","family":"Owosho","sequence":"first","affiliation":[{"name":"Department of Diagnostic Sciences, College of Dentistry, The University of Tennessee Health Sciences Center, Memphis, TN 38163, USA"},{"name":"Department of Otolaryngology\u2014Head & Neck Surgery, College of Medicine, The University of Tennessee Health Sciences Center, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"DeColibus","sequence":"additional","affiliation":[{"name":"Division of Oral Diagnosis, Department of Diagnostic Sciences, College of Dentistry, The University of Tennessee Health Sciences Center, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Hedgepeth","sequence":"additional","affiliation":[{"name":"Division of Oral Diagnosis, Department of Diagnostic Sciences, College of Dentistry, The University of Tennessee Health Sciences Center, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burton C.","family":"Wood","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2014Head & Neck Surgery, College of Medicine, The University of Tennessee Health Sciences Center, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritter E.","family":"Sansoni","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2014Head & Neck Surgery, College of Medicine, The University of Tennessee Health Sciences Center, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0325-5637","authenticated-orcid":false,"given":"John P.","family":"Gleysteen","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2014Head & Neck Surgery, College of Medicine, The University of Tennessee Health Sciences Center, Memphis, TN 38163, USA"},{"name":"Division of Head and Neck Surgical Oncology, The University of Tennessee Health Sciences Center, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, College of Medicine, The University of Tennessee Health Sciences Center, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2015.12.008","article-title":"Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation","volume":"118","author":"Romesser","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jamaoto.2013.6777","article-title":"A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer","volume":"140","author":"Lohia","year":"2014","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2011.05.028","article-title":"Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer","volume":"101","author":"Simone","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.oooo.2016.07.003","article-title":"Comparison of mean radiation dose and dosimetric distribution to tooth-bearing regions of the mandible associated with proton beam radiation therapy and intensity-modulated radiation therapy for ipsilateral head and neck tumor","volume":"122","author":"Owosho","year":"2016","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12032-017-0950-1","article-title":"Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer","volume":"34","author":"Franco","year":"2017","journal-title":"Med. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.jcms.2016.06.008","article-title":"Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT)","volume":"44","author":"Owosho","year":"2016","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jcms.2017.01.020","article-title":"The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines","volume":"45","author":"Owosho","year":"2017","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamaoto.2022.4165","article-title":"Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients with Head and Neck Cancer","volume":"149","author":"Singh","year":"2022","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.oraloncology.2016.11.015","article-title":"The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience","volume":"64","author":"Owosho","year":"2017","journal-title":"Oral Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/08880018.2016.1219797","article-title":"Long-term effect of chemotherapy-intensity-modulated radiation therapy (chemo-IMRT) on dentofacial development in head and neck rhabdomyosarcoma patients","volume":"33","author":"Owosho","year":"2016","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(01)02683-9","article-title":"Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer","volume":"52","author":"Antonadou","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.radonc.2003.10.005","article-title":"Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients","volume":"70","author":"Rades","year":"2004","journal-title":"Radiother. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Oberoi, S., Zamperlini-Netto, G., Beyene, J., Treister, N.S., and Sung, L. (2014). Effect of prophylactic low level laser therapy on oral mucositis: A systematic review and meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107418"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.oooo.2020.05.014","article-title":"Low-level laser therapy in the prevention and treatment of oral mucositis: A systematic review and meta-analysis","volume":"130","author":"Peng","year":"2020","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Amiri Khosroshahi, R., Talebi, S., Travica, N., and Mohammadi, H. (2022). Cryotherapy for oral mucositis in cancer: Review of systematic reviews and meta-analysis. BMJ Support. Palliat. Care.","DOI":"10.1136\/spcare-2022-003636"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103276","DOI":"10.1016\/j.critrevonc.2021.103276","article-title":"Effectiveness of low level laser therapy versus cryotherapy in cancer patients with oral mucositis: Systematic review and network meta-analysis","volume":"160","author":"Lai","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00520-010-0847-4","article-title":"A systematic review of trismus induced by cancer therapies in head and neck cancer patients","volume":"18","author":"Bensadoun","year":"2010","journal-title":"Support. Care Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.oraloncology.2004.04.003","article-title":"Trismus in head and neck oncology: A systematic review","volume":"40","author":"Dijkstra","year":"2004","journal-title":"Oral Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijom.2005.08.001","article-title":"Criteria for trismus in head and neck oncology","volume":"35","author":"Dijkstra","year":"2006","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00520-007-0345-5","article-title":"Radiation-induced trismus in head and neck cancer patients","volume":"16","author":"Brennan","year":"2008","journal-title":"Support. Care Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3109\/0284186X.2012.744466","article-title":"The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer","volume":"52","author":"Pauli","year":"2013","journal-title":"Acta Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.oooo.2014.10.003","article-title":"Postradiation trismus and its impact on quality of life in patients with head and neck cancer","volume":"119","author":"Lee","year":"2015","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ijrobp.2008.05.024","article-title":"Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers","volume":"73","author":"Gomez","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijrobp.2003.08.004","article-title":"Intensity-modulated radiation therapy for oropharyngeal carcinoma: Impact of tumor volume","volume":"59","author":"Chao","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1758-3284-2-28","article-title":"Intensity modulated radiotherapy (IMRT) in the management of locally advanced oropharyngeal squamous cell carcinomata (SCC): Disease control and functional outcome using the therapy outcome measure (TOM) score-report from a single U.K. institution","volume":"2","author":"Ingle","year":"2010","journal-title":"Head Neck Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hsieh, L.C., Chen, J.W., Wang, L.Y., Tsang, Y.M., Shueng, P.W., Liao, L.J., Lo, W.C., Lin, Y.C., Tseng, C.F., and Kuo, Y.S. (2014). Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092561"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/0284186X.2015.1037864","article-title":"Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer","volume":"55","author":"Rao","year":"2016","journal-title":"Acta Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.oraloncology.2015.01.016","article-title":"Mouth opening in patients irradiated for head and neck cancer: A prospective repeated measures study","volume":"51","author":"Kamstra","year":"2015","journal-title":"Oral Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/0284186X.2014.892209","article-title":"Radiation-induced trismus in the ARTSCAN head and neck trial","volume":"53","author":"Lindblom","year":"2014","journal-title":"Acta Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hed.20760","article-title":"Trismus in patients with oropharyngeal cancer: Relationship with dose in structures of mastication apparatus","volume":"30","author":"Teguh","year":"2008","journal-title":"Head Neck"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/hed.24859","article-title":"Exercise therapy for trismus secondary to head and neck cancer: A systematic review","volume":"39","author":"Kamstra","year":"2017","journal-title":"Head Neck"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.oraloncology.2006.04.003","article-title":"Exercise therapy for trismus in head and neck cancer","volume":"43","author":"Dijkstra","year":"2007","journal-title":"Oral Oncol."},{"key":"ref_37","first-page":"E35","article-title":"Dynasplint for the management of trismus after treatment of upper aerodigestive tract cancer: A retrospective study","volume":"91","author":"Dijkstra","year":"2012","journal-title":"Ear. Nose Throat J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00520-012-1610-9","article-title":"TheraBite exercises to treat trismus secondary to head and neck cancer","volume":"21","author":"Kamstra","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0360-3016(94)90104-X","article-title":"Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy","volume":"28","author":"Bjordal","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hed.10129","article-title":"Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long-term survivors","volume":"24","author":"Wijers","year":"2002","journal-title":"Head Neck"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1054\/bjoc.2001.2038","article-title":"Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists","volume":"85","author":"Coppes","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Lombaert, I.M., Brunsting, J.F., Wierenga, P.K., Faber, H., Stokman, M.A., Kok, T., Visser, W.H., Kampinga, H.H., de Haan, G., and Coppes, R.P. (2008). Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002063"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","article-title":"A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results","volume":"49","author":"Chao","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0167-8140(94)90006-X","article-title":"The early changes in salivary gland function during and after radiotherapy given for head and neck cancer","volume":"30","author":"Leslie","year":"1994","journal-title":"Radiother. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2004.12.076","article-title":"Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy","volume":"62","author":"Blanco","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/0284186X.2013.831186","article-title":"The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia","volume":"53","author":"Beetz","year":"2014","journal-title":"Acta Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ijrobp.2011.04.020","article-title":"Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: An independent test of QUANTEC criteria using a prospectively collected dataset","volume":"82","author":"Moiseenko","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.adaj.2015.09.014","article-title":"Efficacy and safety of pilocarpine for radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis","volume":"147","author":"Cheng","year":"2016","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.21.01208","article-title":"Salivary Gland Hypofunction and\/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO\/MASCC\/ASCO Guideline","volume":"39","author":"Mercadante","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0278-2391(83)90294-X","article-title":"Osteoradionecrosis: A new concept of its pathophysiology","volume":"41","author":"Marx","year":"1983","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0278-2391(87)90399-5","article-title":"Osteoradionecrosis: Clinical experience and a proposal for classification","volume":"45","author":"Epstein","year":"1987","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0030-4220(94)90224-0","article-title":"Hyperbaric oxygen treatment of osteoradionecrosis of the mandible with repeated pathologic fracture. Report of a case","volume":"77","author":"Balm","year":"1994","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1046\/j.1365-2273.2000.00367.x","article-title":"Mandibular osteoradionecrosis: Clinical behaviour and diagnostic aspects","volume":"25","author":"Store","year":"2000","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2008.12.052","article-title":"Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients","volume":"75","author":"Lee","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1200\/JCO.2004.09.959","article-title":"Mandibular osteoradionecrosis","volume":"22","author":"Mendenhall","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.joms.2009.02.008","article-title":"Osteoradionecrosis of the mandible: Treatment outcomes and factors influencing the progress of osteoradionecrosis","volume":"67","author":"Oh","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijrobp.2005.10.021","article-title":"Osteoradionecrosis prevention myths","volume":"64","author":"Wahl","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcms.2015.03.024","article-title":"Osteoradionecrosis of the mandible: A ten year single-center retrospective study","volume":"43","author":"Chronopoulos","year":"2015","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2012.05.032","article-title":"Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer","volume":"85","author":"Tsai","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00066-015-0875-6","article-title":"Risk profile for osteoradionecrosis of the mandible in the IMRT era","volume":"192","author":"Studer","year":"2016","journal-title":"Strahlenther. Onkol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/CCO.0000000000000181","article-title":"Proton therapy for head and neck cancer","volume":"27","author":"Lukens","year":"2015","journal-title":"Curr. Opin. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00066-004-1171-z","article-title":"Osteoradionecrosis of the mandibula in patients treated with different fractionations","volume":"180","author":"Studer","year":"2004","journal-title":"Strahlenther. Onkol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13063-017-2376-7","article-title":"HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible: Study protocol for a randomised controlled trial","volume":"19","author":"Shaw","year":"2018","journal-title":"Trials"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijom.2018.08.007","article-title":"Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: A systematic review of the literature and meta-analysis","volume":"48","author":"Kolokythas","year":"2019","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e20170172","DOI":"10.1590\/1678-7757-2017-0172","article-title":"Osteoradionecrosis of the jaws: Case series treated with adjuvant low-level laser therapy and antimicrobial photodynamic therapy","volume":"26","author":"Ribeiro","year":"2018","journal-title":"J. Appl. Oral Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00198-017-4343-2","article-title":"Teriparatide therapy for severe, refractory osteoradionecrosis of the jaw","volume":"29","author":"Cha","year":"2018","journal-title":"Osteoporos. Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1368-8375(01)00105-1","article-title":"Rhabdomyosarcoma of the head and neck in children","volume":"38","author":"Hicks","year":"2002","journal-title":"Oral Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/1097-0142(19871115)60:10<2570::AID-CNCR2820601037>3.0.CO;2-Q","article-title":"The long-term effects of treatment on the dental condition of children surviving malignant disease","volume":"60","author":"Maguire","year":"1987","journal-title":"Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1096-911X(199910)33:4<362::AID-MPO4>3.0.CO;2-I","article-title":"Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and-III. IRS Group of the Children\u2019s Cancer Group and the Pediatric Oncology Group","volume":"33","author":"Raney","year":"1999","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mpo.2950250209","article-title":"Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma","volume":"25","author":"Kaste","year":"1995","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1002\/cncr.24670","article-title":"Impact of radiation and chemotherapy on risk of dental abnormalities: A report from the Childhood Cancer Survivor Study","volume":"115","author":"Kaste","year":"2009","journal-title":"Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2214\/ajr.162.6.8192008","article-title":"Abnormal odontogenesis in children treated with radiation and chemotherapy: Imaging findings","volume":"162","author":"Kaste","year":"1994","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: Clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-8587(13)70203-1","article-title":"Endocrine aspects of bone metastases","volume":"2","author":"Hofbauer","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","article-title":"Sunitinib related osteonecrosis of jaw: A case report","volume":"113","author":"Fleissig","year":"2012","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"26","author":"Estilo","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/j.bjoms.2013.09.008","article-title":"Osteonecrosis of the jaw related to everolimus: A case report","volume":"51","author":"Kim","year":"2013","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.oraloncology.2015.08.014","article-title":"Osteonecrosis of the jaw a new complication related to Ipilimumab","volume":"51","author":"Owosho","year":"2015","journal-title":"Oral Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.21037\/jgo.2016.05.07","article-title":"Osteonecrosis of the jaw associated with ziv-aflibercept","volume":"7","author":"Mawardi","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00520-018-4501-x","article-title":"Osteonecrosis of the jaw related to non-antiresorptive medications: A systematic review","volume":"27","author":"Kouri","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","article-title":"Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention","volume":"125","author":"Owosho","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study","volume":"126","author":"Hallmer","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.oraloncology.2012.03.009","article-title":"Tooth extraction in patients on zoledronic acid therapy","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","article-title":"Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: A cohort study","volume":"41","author":"Yamazaki","year":"2012","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.joms.2013.01.006","article-title":"Tooth extractions in intravenous bisphosphonate-treated patients: A refined protocol","volume":"71","author":"Scoletta","year":"2013","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/annonc\/mdu544","article-title":"Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: Final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12","volume":"26","author":"Gnant","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant denosumab in breast cancer (ABCSG-18): A multicentre, randomised, double-blind, placebo-controlled trial","volume":"386","author":"Gnant","year":"2015","journal-title":"Lancet"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00520-020-05556-0","article-title":"Long-term impact of bone-modifying agents for the treatment of bone metastases: A systematic review","volume":"29","author":"Ng","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00774-014-0566-x","article-title":"Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases","volume":"33","author":"Bramati","year":"2015","journal-title":"J. Bone Miner. Metab."},{"key":"ref_94","first-page":"b147","article-title":"Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: A review of 282 patients","volume":"77","author":"Bonacina","year":"2011","journal-title":"J. Can. Dent. Assoc."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","article-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid","volume":"20","author":"Dimopoulos","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/SPC.0000000000000219","article-title":"Prevention and management of osteonecrosis of the jaw secondary to bone-targeted therapy in patients with kidney cancer","volume":"10","author":"Ripamonti","year":"2016","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: Pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.oooo.2016.06.019","article-title":"Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: An observational retrospective study of initial case series","volume":"122","author":"Owosho","year":"2016","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.4317\/medoral.18812","article-title":"Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy","volume":"18","author":"Vescovi","year":"2013","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/SCS.0000000000001665","article-title":"Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: Surgical protocol supported by low-level laser therapy","volume":"26","author":"Vescovi","year":"2015","journal-title":"J. Craniofac. Surg."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.19.02192","article-title":"Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial","volume":"38","author":"Sim","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-Related Osteonecrosis of the Jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.oraloncology.2006.12.006","article-title":"A decision analysis: The dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantation","volume":"44","author":"Elad","year":"2008","journal-title":"Oral Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbmt.2015.09.014","article-title":"The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review","volume":"22","author":"Chaudhry","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.bbmt.2019.01.026","article-title":"Salivary Changes before and after Hematopoietic Stem Cell Transplantation: A Systematic Review","volume":"25","author":"Potting","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.moh.0000245689.47333.ff","article-title":"Chronic graft versus host disease","volume":"13","author":"Baird","year":"2006","journal-title":"Curr. Opin. Hematol"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1601-0825.2008.01448.x","article-title":"Oral graft-versus-host disease","volume":"14","author":"Imanguli","year":"2008","journal-title":"Oral Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00520-021-06535-9","article-title":"Xerostomia: An immunotherapy-related adverse effect in cancer patients","volume":"30","author":"Bustillos","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_110","first-page":"807","article-title":"Severe Oral Mucositis: A Rare Adverse Event of Pembrolizumab","volume":"17","author":"Lederhandler","year":"2018","journal-title":"J. Drugs Dermatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.oraloncology.2016.09.011","article-title":"Squamous cell carcinoma associated with chronic graft versus host disease-like\/lichen planus-like lesion of the oral cavity in a patient managed for metastatic melanoma with a PD-1 inhibitor pembrolizumab","volume":"63","author":"Owosho","year":"2016","journal-title":"Oral Oncol."}],"container-title":["Dentistry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2304-6767\/11\/5\/136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:36:37Z","timestamp":1760124997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2304-6767\/11\/5\/136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":111,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["dj11050136"],"URL":"https:\/\/doi.org\/10.3390\/dj11050136","relation":{},"ISSN":["2304-6767"],"issn-type":[{"value":"2304-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]}}}